News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
298,027 Results
Type
Article (15130)
Company Profile (300)
Press Release (282597)
Section
Business (93839)
Career Advice (190)
Deals (15817)
Drug Delivery (45)
Drug Development (52105)
Employer Resources (39)
FDA (6399)
Job Trends (6686)
News (163850)
Policy (11132)
Tag
Academia (986)
Alliances (23771)
Alzheimer's disease (764)
Approvals (6367)
Artificial intelligence (74)
Bankruptcy (106)
Best Places to Work (5339)
Biotechnology (247)
Breast cancer (79)
Cancer (795)
Cardiovascular disease (76)
Career advice (164)
CAR-T (66)
Cell therapy (201)
Clinical research (41245)
Collaboration (273)
Compensation (110)
COVID-19 (1073)
C-suite (81)
Cystic fibrosis (68)
Data (858)
Diabetes (85)
Diagnostics (1896)
Earnings (35426)
Events (49562)
Executive appointments (229)
FDA (6741)
Funding (293)
Gene editing (55)
Gene therapy (160)
GLP-1 (344)
Government (1204)
Healthcare (7899)
Infectious disease (1119)
Inflammatory bowel disease (98)
IPO (8306)
Job creations (1613)
Job search strategy (158)
Layoffs (200)
Legal (1537)
Lung cancer (122)
Manufacturing (105)
Medical device (3894)
Medtech (3896)
Mergers & acquisitions (7647)
Metabolic disorders (260)
Neuroscience (988)
NextGen Class of 2024 (2432)
Non-profit (1046)
Northern California (1048)
Obesity (140)
Opinion (97)
Parkinson's disease (67)
Patents (57)
People (28666)
Phase I (14714)
Phase II (19134)
Phase III (12104)
Pipeline (377)
Postmarket research (886)
Preclinical (6066)
Radiopharmaceuticals (213)
Rare diseases (182)
Real estate (3158)
Regulatory (9097)
Research institute (1012)
Southern California (956)
Startups (2126)
United States (8644)
Vaccines (185)
Weight loss (96)
Date
Today (79)
Last 7 days (252)
Last 30 days (2137)
Last 365 days (22676)
2024 (21332)
2023 (24685)
2022 (31084)
2021 (32254)
2020 (26974)
2019 (19348)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (182)
Arizona (56)
Asia (19143)
Australia (3208)
California (2392)
Canada (806)
China (189)
Colorado (101)
Connecticut (94)
Europe (40976)
Florida (268)
Georgia (68)
Illinois (160)
Indiana (80)
Kansas (57)
Maryland (347)
Massachusetts (1865)
Michigan (73)
Minnesota (115)
New Jersey (603)
New York (680)
North Carolina (450)
Northern California (1048)
Ohio (87)
Pennsylvania (480)
South America (304)
Southern California (956)
Texas (271)
Washington State (238)
298,027 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
November 21, 2024
·
4 min read
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
Press Releases
Flashpoint Therapeutics Announces $50M KAIMRC Partnership and Clinical Pipeline Expansion
November 14, 2024
·
3 min read
Press Releases
Adcentrx Therapeutics Doses First Patient in Phase 1b Expansion Cohorts with ADRX-0706 Nectin-4 ADC
December 3, 2024
·
3 min read
Press Releases
New Funding Secured to Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
October 24, 2024
·
2 min read
Press Releases
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
October 24, 2024
·
6 min read
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Rakovina Therapeutics Inc. is pleased to announce the expansion of two research collaborations to align with its recently announced collaboration with the Deep Docking AI Drug Discovery Platform.
May 8, 2024
·
6 min read
Policy
Global Nonprofit CureDuchenne to Host Informational Webinars Following FDA Label Expansion of Sarepta Therapeutics’ Gene Therapy, ELEVIDYS
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, will host webinars in English and Spanish for the Duchenne community after the U.S. Food and Drug Administration approved the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics to include individuals with Duchenne muscular dystrophy with a confirmed mutation in the DMD gene who are at least 4 years of age.
June 20, 2024
·
1 min read
Genetown
Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.
June 10, 2024
·
5 min read
1 of 29,803
Next
